Markets › India › NSE › IPCALAB

Ipca Laboratories Ltd

NSE:IPCALABHealthcareNSE:CNX500NSE:CNXPHARMA

₹1,814.50−0.99%At closeAt close · Mon 19 Oct · ≈ AED 70.01 · Market cap $4.89B · Next earnings Mon 9 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	65.0%	62.1%	59.6%	63.0%	65.5%	64.1%	—	—
Operating margin	43.4%	39.3%	36.3%	38.4%	41.0%	24.2%	24.2%	+0.0 pts
Net margin	21.0%	15.2%	7.5%	7.1%	8.3%	11.8%	16.3%	+4.5 pts
EBITDA margin	27.8%	21.9%	15.1%	16.4%	18.6%	20.3%	—	—
Return on equity	24.2%	16.1%	8.1%	8.6%	10.6%	14.2%	16.5%	+2.4 pts
Return on assets	18.8%	11.6%	5.5%	4.9%	6.3%	9.2%	12.7%	+3.5 pts
Return on capital employed	48.0%	37.2%	33.2%	33.9%	39.1%	23.2%	—	—
Debt / equity	0.1×	0.1×	0.3×	0.2×	0.2×	0.1×	0.1×	−15.3%
Debt / assets	4.4%	10.6%	17.2%	13.0%	11.6%	6.5%	—	—
Interest coverage	209.2×	224.5×	49.5×	22.8×	41.7×	30.7×	—	—
Current ratio	3.0×	3.0×	2.9×	2.4×	2.5×	2.8×	2.8×	+0.0%
Quick ratio	1.6×	1.8×	1.9×	1.3×	1.4×	1.6×	—	—
Cash ratio	0.1×	0.2×	0.7×	0.1×	0.1×	0.2×	0.2×	+0.0%
Asset turnover	0.9×	0.8×	0.7×	0.7×	0.8×	0.8×	—	—
Inventory turnover	1.2×	1.2×	1.4×	1.2×	1.2×	1.3×	—	—
Receivables turnover	6.6×	6.4×	6.3×	4.5×	4.7×	4.7×	—	—
Dividend payout	8.9%	11.5%	21.5%	9.3%	13.8%	4.6%	—	—